<DOC>
	<DOCNO>NCT01017263</DOCNO>
	<brief_summary>The purpose study assess effect chronic administration Vyvanse ( lis-dexamphetamine ) glucose metabolism sample child adolescent Attention Deficit Hyperactivity Disorder ( ADHD ) also glucose intolerance obese .</brief_summary>
	<brief_title>Vyvanse Glucose Intolerance Children With Attention Deficit Hyperactivity Disorder ( ADHD ) Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Dextroamphetamine</mesh_term>
	<criteria>male female , age 8 17 Body Mass Index &gt; 30 fast blood sugar 90100 mg/dl 2 hour post prandial &gt; 140 &lt; 180 mg/dl meet criteria diagnosis ADHD , subtype know cardiovascular disease diabetes structural cardiac abnormality , abnormal ECGs , family history sudden death positive urine drug screen fast blood sugar level &gt; 126 mg/dl HbA1c &gt; 6.5 % Weight &gt; 300 lb</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Glucose Intolerance</keyword>
	<keyword>Obesity</keyword>
	<keyword>Vyvanse</keyword>
</DOC>